California State Teachers Retirement System Inhibrx, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.76 - $39.56 $18,247 - $22,034	-557 Reduced 2.41%	22,593 $789,000
Q4 2023 Feb 13, 2024	SELL	$14.5 - $38.0 $109,533 - $287,052	-7,554 Reduced 24.6%	23,150 $879,000
Q3 2023 Nov 14, 2023	SELL	$15.75 - $26.31 $58,794 - $98,215	-3,733 Reduced 10.84%	30,704 $563,000
Q2 2023 Aug 21, 2023	SELL	$16.96 - $27.82 $10,701 - $17,554	-631 Reduced 1.8%	34,437 $893,000
Q1 2023 May 09, 2023	BUY	$18.45 - $27.14 $31,438 - $46,246	1,704 Added 5.11%	35,068 $661,000
Q4 2022 Feb 14, 2023	BUY	$20.18 - $33.33 $34,023 - $56,194	1,686 Added 5.32%	33,364 $822,000
Q3 2022 Nov 18, 2022	SELL	$11.58 - $24.73 $1,007 - $2,151	-87 Reduced 0.27%	31,678 $569,000
Q2 2022 Aug 15, 2022	BUY	$8.52 - $25.26 $96,148 - $285,059	11,285 Added 55.1%	31,765 $361,000
Q1 2022 May 16, 2022	SELL	$19.89 - $43.18 $53,265 - $115,636	-2,678 Reduced 11.56%	20,480 $456,000
Q4 2021 Feb 15, 2022	BUY	$26.75 - $46.02 $8,961 - $15,416	335 Added 1.47%	23,158 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$25.18 - $37.81 $394,369 - $592,180	-15,662 Reduced 40.7%	22,823 $760,000
Q2 2021 Aug 16, 2021	BUY	$14.69 - $27.52 $384,775 - $720,831	26,193 Added 213.09%	38,485 $1.06 Million
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $196,180 - $614,600	12,292 New	12,292 $405,000

Others Institutions Holding INBX

# of Institutions

Shares Held

18.6K

Call Options Held

Put Options Held

Credit Suisse Ag Zurich, V8

18.6K
Shares

$278,600
0.0% of portfolio

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $586M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account